NCT04272775View on ClinicalTrials.gov

A Study of MLN9708 in Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM)

PHASE1TerminatedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

June 5, 2012

Primary Completion Date

February 15, 2019

Study Completion Date

February 15, 2019

Conditions

Relapsed and/or Refractory Multiple Myeloma

Interventions

DRUG

Ixazomib

Ixazomib capsules.

DRUG

Lenalidomide

Lenalidomide capsules.

DRUG

Dexamethasone

Dexamethasone tablets.

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Takeda

INDUSTRY

NCT04272775 - A Study of MLN9708 in Japanese Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) | Biotech Hunter | Biotech Hunter